Quantitative estimation of regional brain iron with magnetic resonance imaging (Q48330063)

10 February 2018

title

Quantitative estimation of regional brain iron with magnetic resonance imaging (English)

1 reference

10 February 2018

author name string

W R Wayne Martin

series ordinal

1 reference

10 February 2018

publication date

1 December 2009

1 reference

10 February 2018

Parkinsonism and Related Disorders

published in

1 reference

10 February 2018

volume

15 Suppl 3

1 reference

10 February 2018

page(s)

S215-8

1 reference

10 February 2018

Ageing and Parkinson's disease: substantia nigra regional selectivity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Brain iron homeostasis and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Iron, brain ageing and neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

The effect of age on the non-haemin iron in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Interaction of neuromelanin and iron in substantia nigra and other areas of human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Magnetic resonance imaging of brain iron

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

T2 relaxation time in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Estimation of brain iron in vivo by means of the interecho time dependence of image contrast

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

MRI assessment of basal ganglia iron deposition in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Increasing striatal iron content associated with normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Basal ganglia iron content in Parkinson's disease measured with magnetic resonance.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Increased basal ganglia iron in striatonigral degeneration: in vivo estimation with magnetic resonance.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Multiple gradient echo sequence optimized for rapid, single-scan mapping of R(2)(*) at high B0.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Midbrain iron content in early Parkinson disease: a potential biomarker of disease status

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Neurochemical organization of the human basal ganglia: anatomofunctional territories defined by the distributions of calcium-binding proteins and SMI-32.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Imaging iron stores in the brain using magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

Localization of the subthalamic nucleus: optimization with susceptibility-weighted phase MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970818-1

7 January 2021

10.1016/S1353-8020(09)70818-1

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018